﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Aidsmap news - English</title>
    <description> </description>
    <link>http://www.aidsmap.com/Aidsmap-news-English/page/1260794/</link>
    <language>en-gb</language>
    <copyright>NAM Publications - 2013</copyright>
    <pubDate>Thu, 21 Mar 2013 20:52:04 GMT</pubDate>
    <lastBuildDate>Thu, 21 Mar 2013 20:52:04 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Self-testing and home treatment initiation triples uptake of HIV treatment in Malawi</title>
      <description>Offering people the opportunity to self-test at home and
then start antiretroviral therapy after counselling at home, together with home
delivery of antiretroviral drugs, increased the number of people linked to care
after testing and started on treatment almost threefold, a randomised study in
Malawi has shown.
The findings, presented last week at the 20th
Conference</description>
      <link>http://www.aidsmap.com/Self-testing-and-home-treatment-initiation-triples-uptake-of-HIV-treatment-in-Malawi/page/2605852/</link>
      <category>CROI</category>
      <category>CROI 2013</category>
      <category>Malawi</category>
      <category>Promoting HIV testing</category>
      <category>Retention and linkage to care</category>
      <category>Starting treatment</category>
      <author>Keith Alcorn</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2605852/</guid>
      <pubDate>Thu, 21 Mar 2013 08:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Routine tests prompted by electronic patient records increase rates of STI diagnoses among HIV-positive people in London</title>
      <description>The implementation of systematic, frequent
and routine screening for sexually transmitted infections (STIs) led to a
significant increase in the number of infections detected among HIV-positive
people in London, investigators report in HIV
Medicine. Doctors and nurses caring for HIV-positive people were prompted
to carry out an annual STI screen by an electronic patient records</description>
      <link>http://www.aidsmap.com/Routine-tests-prompted-by-electronic-patient-records-increase-rates-of-STI-diagnoses-among-HIV-positive-people-in-London/page/2585538/</link>
      <category>Sexually transmitted infections</category>
      <category>United Kingdom</category>
      <category>United Kingdom</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2585538/</guid>
      <pubDate>Thu, 21 Mar 2013 07:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Sofosbuvir plus ribavirin works well for hard-to-treat inner-city hepatitis C patients</title>
      <description>A simple 24-week oral regimen consisting of
sofosbuvir plus full-dose ribavirin cured nearly 70% of previously untreated
people with genotype 1 hepatitis C, many of whom had factors predictive of poor
response, researchers
reported last week
at the 20th&amp;#160;Conference
on&amp;#160;Retroviruses&amp;#160;and Opportunistic Infections (CROI
2013) in Atlanta.
Direct-acting antiviral agents that target
various steps of the hepatitis C virus (HCV)</description>
      <link>http://www.aidsmap.com/Sofosbuvir-plus-ribavirin-works-well-for-hard-to-treat-inner-city-hepatitis-C-patients/page/2605337/</link>
      <category>CROI</category>
      <category>CROI 2013</category>
      <category>Delivery of care</category>
      <category>New and experimental hepatitis C treatment</category>
      <category>United States</category>
      <author>Liz Highleyman</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2605337/</guid>
      <pubDate>Wed, 20 Mar 2013 07:40:00 GMT</pubDate>
    </item>
    <item>
      <title>AbbVie interferon-free combinations cure most newly treated hepatitis C patients</title>
      <description>All-oral regimens consisting of the HCV protease
inhibitor ABT-450, a non-nucleoside polymerase inhibitor and ribavirin led to
sustained response for more than 90% of previously untreated hepatitis&amp;#160; C patients – including those with unfavourable IL28B gene
patterns – but only about
half of prior non-responders, researchers reported earlier this month at the 20th&amp;#160;Conference
on&amp;#160;Retroviruses&amp;#160;and Opportunistic</description>
      <link>http://www.aidsmap.com/AbbVie-interferon-free-combinations-cure-most-newly-treated-hepatitis-C-patients/page/2605367/</link>
      <category>CROI</category>
      <category>CROI 2013</category>
      <category>New and experimental hepatitis C treatment</category>
      <category>United States</category>
      <author>Liz Highleyman</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2605367/</guid>
      <pubDate>Wed, 20 Mar 2013 07:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Lukewarm reaction to government’s sexual health framework for England</title>
      <description>Just two weeks before local authorities take over the
commissioning of sexual health services – and twelve years since a sexual
health strategy was last published – the Department of Health has released a
“framework” which outlines the government’s ambitions for the improvement of
sexual health in England.
Reaction has not been entirely positive. “The</description>
      <link>http://www.aidsmap.com/Lukewarm-reaction-to-governments-sexual-health-framework-for-England/page/2606010/</link>
      <category>HIV prevention policy</category>
      <category>Policy</category>
      <category>Sexually transmitted infections</category>
      <category>UK health services</category>
      <category>United Kingdom</category>
      <category>United Kingdom</category>
      <author>Roger Pebody</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2606010/</guid>
      <pubDate>Tue, 19 Mar 2013 12:20:00 GMT</pubDate>
    </item>
    <item>
      <title>HIV increases the risk of heart attack, even in people with a suppressed viral load</title>
      <description>Infection with HIV is associated with an
increased risk of heart attack, investigators from the United States report in
the Journal of the American Medical
Association Internal Medicine. Importantly, this finding was based upon
comparison of HIV-positive and HIV-negative individuals with the same
demographic and cardiovascular-risk profiles. Overall, infection with HIV was
associated with a 50%</description>
      <link>http://www.aidsmap.com/HIV-increases-the-risk-of-heart-attack-even-in-people-with-a-suppressed-viral-load/page/2596149/</link>
      <category>Cardiovascular disease</category>
      <category>United States</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2596149/</guid>
      <pubDate>Tue, 19 Mar 2013 08:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Even moderate alcohol consumption increases risk of death for people with chronic hepatitis C</title>
      <description>Moderate alcohol consumption - as little as one or two drinks per day -&amp;#160; is associated
with an increased risk of mortality for people with chronic hepatitis C virus
(HCV) infection, according to research conducted in the United States and
published in Alimentary Pharmacology and
Therapeutics. HCV-infected patients consuming between 1 and 19g of</description>
      <link>http://www.aidsmap.com/Even-moderate-alcohol-consumption-increases-risk-of-death-for-people-with-chronic-hepatitis-C/page/2596574/</link>
      <category>Alcohol</category>
      <category>Hepatitis C</category>
      <category>United States</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2596574/</guid>
      <pubDate>Mon, 18 Mar 2013 06:50:00 GMT</pubDate>
    </item>
    <item>
      <title>French researchers report 14 patients in 'remission' after controlling HIV for over 4 years off treatment</title>
      <description>Two
weeks ago, the
announcement that a baby had been ‘functionally cured’ of HIV disease with the
use of very early antiretroviral therapy (ART) caused great excitement at
the start of the Conference on Retroviruses and Opportunistic Infections (CROI 2013). Now
a study from France has found 14 adult patients who also started a course</description>
      <link>http://www.aidsmap.com/French-researchers-report-14-patients-in-remission-after-controlling-HIV-for-over-4-years-off-treatment/page/2602347/</link>
      <category>France</category>
      <category>France</category>
      <category>HIV testing</category>
      <category>How HIV causes disease</category>
      <category>Must see</category>
      <category>The search for a cure</category>
      <category>Treatment interruptions</category>
      <author>Gus Cairns</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2602347/</guid>
      <pubDate>Sat, 16 Mar 2013 14:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Are we underestimating the proportion of virally-suppressed patients in the US?</title>
      <description>Several presentations at the recent 20th
Conference on Retroviruses and Opportunistic Infections in Atlanta suggest that previous estimates of the proportion of
people with HIV in the USA who are on antiretroviral therapy (ART) and with an
undetectable viral load may have been too low and may be closer to the
proportion virally suppressed</description>
      <link>http://www.aidsmap.com/Are-we-underestimating-the-proportion-of-virally-suppressed-patients-in-the-US/page/2600686/</link>
      <category>CROI</category>
      <category>Access to medicines and treatment</category>
      <category>CROI 2013</category>
      <category>France</category>
      <category>France</category>
      <category>Infectiousness and treatment as prevention</category>
      <category>New York</category>
      <category>Retention and linkage to care</category>
      <category>Seattle</category>
      <category>Structural factors</category>
      <category>United Kingdom</category>
      <category>United Kingdom</category>
      <category>United States</category>
      <author>Gus Cairns</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2600686/</guid>
      <pubDate>Fri, 15 Mar 2013 08:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Lopinavir/ritonavir equivalent to nevirapine in Ugandan children</title>
      <description>A ritonavir-boosted lopinavir (LPV/r)-based
regimen achieved a comparable rate of virologic suppression when compared to a non-nucleoside
reverse transcriptase inhibitor (NNRTI)-based regimen in HIV-infected Ugandan
children at 48 weeks, with comparable immunological responses and adverse
events, researchers reported at the 20th
Conference on Retroviruses and Opportunistic Infections(CROI 2013) last
week in Atlanta.
These findings from the Prevention</description>
      <link>http://www.aidsmap.com/Lopinavirritonavir-equivalent-to-nevirapine-in-Ugandan-children/page/2598853/</link>
      <category>CROI</category>
      <category>CROI 2013</category>
      <category>HIV treatment in children</category>
      <category>Malaria</category>
      <author>Carole Leach-Lemens</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2598853/</guid>
      <pubDate>Thu, 14 Mar 2013 10:00:00 GMT</pubDate>
    </item>
  </channel>
</rss